rs1805066
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_001172501.3(SLC6A2):c.733G>A(p.Val245Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00879 in 1,614,014 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001172501.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A2 | NM_001172501.3 | c.733G>A | p.Val245Ile | missense_variant | 5/15 | ENST00000568943.6 | NP_001165972.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A2 | ENST00000568943.6 | c.733G>A | p.Val245Ile | missense_variant | 5/15 | 1 | NM_001172501.3 | ENSP00000457473 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00605 AC: 921AN: 152196Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.00607 AC: 1525AN: 251440Hom.: 3 AF XY: 0.00603 AC XY: 819AN XY: 135886
GnomAD4 exome AF: 0.00908 AC: 13273AN: 1461700Hom.: 73 Cov.: 32 AF XY: 0.00880 AC XY: 6400AN XY: 727154
GnomAD4 genome AF: 0.00604 AC: 920AN: 152314Hom.: 4 Cov.: 33 AF XY: 0.00564 AC XY: 420AN XY: 74476
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | SLC6A2: BP4, BS1, BS2 - |
SLC6A2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 07, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at